| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019327682 |
| P356 | DOI | 10.1186/1756-3305-6-109 |
| P932 | PMC publication ID | 3637411 |
| P698 | PubMed publication ID | 23597046 |
| P5875 | ResearchGate publication ID | 236226275 |
| P50 | author | Xinzhuan Su | Q37374247 |
| P2093 | author name string | Jianbing Mu | |
| Lilia Gonzalez-Ceron | |||
| Marco A Sandoval | |||
| Deirdre Joy | |||
| Elena V Choy | |||
| Frida Santillán | |||
| Gerardo Camas | |||
| Rene Torreblanca | |||
| P2860 | cites work | Extensive polymorphism in the plasmodium vivax merozoite surface coat protein MSP-3alpha is limited to specific domains | Q56447214 |
| Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax | Q75650473 | ||
| Determinants of relapse periodicity in Plasmodium vivax malaria | Q17485692 | ||
| History of the discovery of the malaria parasites and their vectors | Q21198929 | ||
| The hypnozoite and relapse in primate malaria | Q24616523 | ||
| Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1 | Q24805474 | ||
| Plasmodium vivax polymorphism in a clinical drug trial | Q28347253 | ||
| GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research--an update | Q29547286 | ||
| Plasmodium vivax merozoite surface protein-3 contains coiled-coil motifs in an alanine-rich central domain | Q30738627 | ||
| Prevention and treatment of vivax malaria | Q33270408 | ||
| Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals | Q33276180 | ||
| Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children | Q33530114 | ||
| Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax | Q33824972 | ||
| Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. | Q33999450 | ||
| Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata | Q34341592 | ||
| Primaquine therapy for malaria | Q34360516 | ||
| Experimental, therapeutic and natural transmission of Plasmodium vivax tertian malaria: scientific and anecdotal data on the history of Dutch malaria studies | Q34554478 | ||
| Genetic diversity of Plasmodium vivax in Kolkata, India | Q35017420 | ||
| Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. | Q35608904 | ||
| Natural relapses in vivax malaria induced by Anopheles mosquitoes | Q36642605 | ||
| Local adaptation and vector-mediated population structure in Plasmodium vivax malaria. | Q36660634 | ||
| Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens. | Q37123836 | ||
| A closer look at multiple-clone Plasmodium vivax infections: detection methods, prevalence and consequences | Q37410892 | ||
| Determination of the Plasmodium vivax relapse pattern in Camopi, French Guiana | Q37475221 | ||
| High frequency of genetic diversity of Plasmodium vivax field isolates in Myanmar | Q38498440 | ||
| High dose of primaquine in primaquine resistant vivax malaria | Q38925712 | ||
| An outbreak of Plasmodium vivax malaria in Far North Queensland, 2002. | Q39044725 | ||
| Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites | Q39094078 | ||
| Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials | Q39143267 | ||
| Patterns of Plasmodium Vivax Recurrences in a High-Incidence Coastal Area of el Salvador, C. A. * | Q39222390 | ||
| Differential susceptibilities of Anopheles albimanus and Anopheles pseudopunctipennis to infections with coindigenous Plasmodium vivax variants VK210 and VK247 in southern Mexico. | Q39509369 | ||
| Evaluation of an alternative scheme of treatment for the control of malaria | Q41918295 | ||
| Plan to improve malaria control towards its elimination in Mesoamerica | Q41930263 | ||
| Studies on the Characterization of Plasmodium Vivax Strains from Central America | Q41935353 | ||
| Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia | Q41937139 | ||
| The participation of secondary clinical episodes in the epidemiology of vivax malaria during pre- and post-implementation of focal control in the state of Oaxaca, Mexico. | Q41938293 | ||
| Frequency of malaria relapse due to Plasmodium vivax in a non-endemic region (São Paulo, Brazil) | Q41942398 | ||
| Merozoite surface protein-3alpha is a reliable marker for population genetic analysis of Plasmodium vivax | Q42138274 | ||
| Prevention of Plasmodium vivax malaria recurrence: efficacy of the standard total dose of primaquine administered over 3 days | Q43298780 | ||
| Plasmodium vivax: ookinete destruction and oocyst development arrest are responsible for Anopheles albimanus resistance to circumsporozoite phenotype VK247 parasites | Q44146320 | ||
| Plasmodium vivax: impaired escape of Vk210 phenotype ookinetes from the midgut blood bolus of Anopheles pseudopunctipennis | Q44169331 | ||
| Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections. | Q44400338 | ||
| Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy | Q44735618 | ||
| Polymorphism at the merozoite surface protein-3alpha locus of Plasmodium vivax: global and local diversity | Q46555323 | ||
| Genetic diversity and multiple infections of Plasmodium vivax malaria in Western Thailand | Q47930983 | ||
| Letter: Malarial relapse mechanism | Q47935982 | ||
| Estimating the relapse risk of Plasmodium vivax in Iran under national chemotherapy scheme using a novel method. | Q48037062 | ||
| Malaria attack: a very late relapse due to Plasmodium vivax | Q48037208 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium vivax | Q311376 |
| P304 | page(s) | 109 | |
| P577 | publication date | 2013-04-18 | |
| P1433 | published in | Parasites and Vectors | Q7135941 |
| P1476 | title | Molecular and epidemiological characterization of Plasmodium vivax recurrent infections in southern Mexico | |
| P478 | volume | 6 |
| Q34989895 | Changing malaria transmission and implications in China towards National Malaria Elimination Programme between 2010 and 2012. |
| Q36393128 | Diversity and evolutionary genetics of the three major Plasmodium vivax merozoite genes participating in reticulocyte invasion in southern Mexico |
| Q36235143 | Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico |
| Q92434486 | Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal |
| Q37586341 | First characterization of Plasmodium vivax liver stage antigen (PvLSA) using synthetic peptides |
| Q33613545 | Geographical variation in Plasmodium vivax relapse |
| Q46014409 | Malaria Epidemiology at the Clone Level. |
| Q89547772 | Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials |
| Q28545982 | Plasmodium vivax Diversity and Population Structure across Four Continents |
| Q64082513 | Prevalence of malaria relapse: systematic review with meta-analysis |
| Q33612431 | Socioeconomic factors, attitudes and practices associated with malaria prevention in the coastal plain of Chiapas, Mexico |
| Q33630458 | Temporal genetic changes in Plasmodium vivax apical membrane antigen 1 over 19 years of transmission in southern Mexico |
| Q28649335 | The Gulf of Mexico: a "hot zone" for neglected tropical diseases? |
| Q26865002 | The utility of genomic data for Plasmodium vivax population surveillance |
Search more.